Suppr超能文献

基因转染至树突状细胞的效率受阳离子脂质体/DNA复合物大小的影响。

Gene transfection efficiency into dendritic cells is influenced by the size of cationic liposomes/DNA complexes.

作者信息

Inoh Yoshikazu, Nagai Mie, Matsushita Kayo, Nakanishi Mamoru, Furuno Tadahide

机构信息

School of Pharmacy, Aichi Gakuin University, 1-100 Kusumoto-cho, Chikusa-ku, Nagoya 464-8650, Japan.

School of Pharmacy, Aichi Gakuin University, 1-100 Kusumoto-cho, Chikusa-ku, Nagoya 464-8650, Japan.

出版信息

Eur J Pharm Sci. 2017 May 1;102:230-236. doi: 10.1016/j.ejps.2017.03.023. Epub 2017 Mar 16.

Abstract

Cationic liposomes have attracted recent attention as DNA vaccine carriers that can target dendritic cells (DCs). In general, cationic liposome/DNA complexes (lipoplexes) are taken up by various cells via clathrin-mediated endocytosis, caveolae-mediated endocytosis, macropinocytosis, or phagocytosis, with the mode of endocytosis determining further intracellular trafficking pathways. Moreover, the physicochemical properties of cationic lipoplexes, including lipid composition, shape, size, and charge, influence transfection efficiency, affecting uptake and subsequent intracellular pathways. To develop cationic liposomes as potential DNA vaccine carriers, the objective of this study was to study the effect of lipoplex size on DNA transfection efficiency in DCs. We explored the size-dependent endocytosis pathway and the intracellular trafficking of cationic lipoplexes using bone marrow derived dendritic cells (BMDCs). Our results indicated that small-sized lipoplexes (approximately 270nm diameter) were taken up by BMDCs via caveolae-mediated endocytosis, which led to a non-degradative pathway, whereas larger-sized lipoplexes (approximately 500nm diameter) were taken up by BMDCs via clathrin-mediated endocytosis and micropinocytosis, which led to a lysosomal degradation pathway. These findings suggest that, by regulating the size of lipoplexes, it may be possible to develop cationic liposomes as DNA vaccine therapies for targeting DCs.

摘要

阳离子脂质体作为能够靶向树突状细胞(DCs)的DNA疫苗载体,最近受到了关注。一般来说,阳离子脂质体/DNA复合物(脂质体转染复合物)通过网格蛋白介导的内吞作用、小窝介导的内吞作用、巨胞饮作用或吞噬作用被各种细胞摄取,内吞作用的方式决定了进一步的细胞内运输途径。此外,阳离子脂质体转染复合物的物理化学性质,包括脂质组成、形状、大小和电荷,会影响转染效率,进而影响摄取和随后的细胞内途径。为了开发阳离子脂质体作为潜在的DNA疫苗载体,本研究的目的是研究脂质体转染复合物大小对DCs中DNA转染效率的影响。我们使用骨髓来源的树突状细胞(BMDCs)探索了阳离子脂质体转染复合物大小依赖性的内吞途径和细胞内运输。我们的结果表明,小尺寸的脂质体转染复合物(直径约270nm)通过小窝介导的内吞作用被BMDCs摄取,这导致了一条非降解途径,而大尺寸的脂质体转染复合物(直径约500nm)通过网格蛋白介导的内吞作用和巨胞饮作用被BMDCs摄取,这导致了一条溶酶体降解途径。这些发现表明,通过调节脂质体转染复合物的大小,有可能开发出作为靶向DCs的DNA疫苗疗法的阳离子脂质体。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验